186 related articles for article (PubMed ID: 11961349)
1. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
[TBL] [Abstract][Full Text] [Related]
2. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
3. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and risk factors of lymphatic metastasis in early gastric cancer].
Wang JM; Zhou LY; Lin SR; Ding SG
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):297-300. PubMed ID: 20627034
[TBL] [Abstract][Full Text] [Related]
6. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
Sakata H; Murakami S; Hirayama R
Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping and biopsy using radioactive tracer in gastric cancer.
Jalaly NY; Valizadeh N; Azizi S; Kamani F; Hassanzadeh M
ANZ J Surg; 2014 Jun; 84(6):454-8. PubMed ID: 22988829
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
10. Risk of lymph node metastasis in differentiated type mucosal early gastric cancer mixed with minor undifferentiated type histology.
Lee JH; Choi IJ; Han HS; Kim YW; Ryu KW; Yoon HM; Eom BW; Kim CG; Lee JY; Cho SJ; Kim YI; Nam BH; Kook MC
Ann Surg Oncol; 2015; 22(6):1813-9. PubMed ID: 25344305
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients.
Zheng Z; Zhang Y; Zhang L; Li Z; Wu X; Liu Y; Bu Z; Ji J
BMC Cancer; 2016 Feb; 16():92. PubMed ID: 26873736
[TBL] [Abstract][Full Text] [Related]
12. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases.
Sunagawa H; Kinoshita T; Kaito A; Shibasaki H; Kaneko K; Ochiai A; Ohtsu A; Nishida T
Surg Today; 2017 Feb; 47(2):202-209. PubMed ID: 27194020
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor.
Ashizawa T; Okada R; Suzuki Y; Takagi M; Yamazaki T; Sumi T; Aoki T; Ohnuma S; Aoki T
Gastric Cancer; 2005; 8(2):124-31. PubMed ID: 15864720
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer.
Lee JH; Choi MG; Min BH; Noh JH; Sohn TS; Bae JM; Kim S
Br J Surg; 2012 Dec; 99(12):1688-92. PubMed ID: 23023388
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of lymph node metastasis in mucosal gastric cancer with extra indication for endoscopic mucosal resection.
Yoshikawa K; Hiki N; Fukunaga T; Tokunaga M; Yamamoto Y; Miki A; Ogawa K; Higashijima J; Ohyama S; Seto Y; Shimada M; Yamaguchi T
J Am Coll Surg; 2009 Jun; 208(6):1045-50. PubMed ID: 19476890
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastasis and macroscopic features in early gastric cancer.
Baba H; Maehara Y; Okuyama T; Orita H; Anai H; Akazawa K; Sugimachi K
Hepatogastroenterology; 1994 Aug; 41(4):380-3. PubMed ID: 7959576
[TBL] [Abstract][Full Text] [Related]
18. Application of minimally invasive treatment for early gastric cancer.
Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer.
Murakami S; Satomi A; Ishida K; Sakata H; Tsuji Y; Hibino S
Oncol Rep; 1996 Jan; 3(1):69-73. PubMed ID: 21594317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
